Drugs
Drug Information
Drug Images
Drugs A to Z
Companies A to Z
Therapeutic Class
Calculators
Specialty
Multidisciplinary
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hepatology
Infectious Diseases
Neurology
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Psychiatry
Respirology
Rheumatology
Urology
Pharmacy
General News
Latest News
Local News
Malpractice & Legal
Policies & Public Health
Career
Health & Wellness
Medical Technology
Medical School
Nurse
E-Learning
Site
Web
Sunday, Sep 25, 2022 |
About Us
|
Contact Us
|
Home
My CPD Log
Doctor's CPD
IDI CME
MIMS CPD
CPD Pharmacist
CME IDI for Doctor
[Terakreditasi]
Current Management of Atopic Dermatitis: Should Patient Use “Emollient Plus” on Skin Care Regimen for Atopic Dermatitis? [SK PB IDI No.: 3667/PB/A.4/10/2021
]
(Dermatology) End Date: 16-Okt-2022
Diagnosis of Peripheral Neuropathy in Daily Practice [SK PB IDI No.: 3666/PB/A.4/10/2021
]
(Neurology) End Date: 19-Okt-2022
Dyslipidemia in Diabetes: Hidden Faces of Diabetes [SK PB IDI No: 0143/PB/A.4/05/2022
]
(Diabetes and Endocrinology) End Date: 20-Mei-2023
Dyslipidemia Management : The Era of LDL – C 1.4 [SK PB IDI No.: 4108/PB/A.4/12/2021
]
(Cardiology) End Date: 22-Jan-2023
Penanganan Nyeri Punggung Bawah Akut dan Kronis: Pendekatan Farmakologi [SK PB IDI No.: 4427/PB/A.4/02/2022
]
(Neurology) End Date: 05-Mar-2023
Pendekatan Terapi Nyeri berdasarkan Patofisiologinya Adakah Peran Penghambat COX-2? [SK PB IDI No..: 0400/PB/A.4/07/2022
]
(Neurology) End Date: 30-Jul-2023
Peranan Glucagon Like Peptide-1 Receptor Agonist pada Terapi Diabetes Melitus Tipe 2 [SK PB IDI No.: 4516/PB/A.4/03/2022
]
(Diabetes and Endocrinology) End Date: 24-Mei-2023
Terapi Insulin Tepat Waktu: Kapan dan Bagaimana Aplikasi Klinisnya? [SK PB IDI No.: 4515/PB/A.4/03/2022
]
(Diabetes and Endocrinology) End Date: 24-Mei-2023
Member Login
Sign-in to MIMS Authentication Service
•
Forgot password?
•
Not a member yet?
MODUL BARU CME
Dyslipidemia in Diabetes: The Hidden Face of Diabetes
(2 SKP IDI)
Pendekatan Terapi Nyeri berdasarkan Patofisiologinya, Adakah Peran Penghambat COX-2?
(5 SKP IDI)
Peranan Glucagon Like Peptide-1 Receptor Agonist pada Terapi Diabetes Melitus Tipe 2
(
2 SKP IDI)
Terapi Insulin Tepat Waktu: Kapan dan Bagaimana Aplikasi Klinisnya?
(
2 SKP IDI)
Panduan untuk User
Panduan Terbaru Mengikuti Modul CME online
Useful Links
Ikatan Dokter Indonesia (IDI)